These results suggest that hyperglycemia increases sclerostin expression by inducing reactive oxygen species and TNF-α expression and that regulation of TNF-α and oxidative stress levels may be a valuable therapeutic strategy for alveolar bone complications in chronically hyperglycemic patients [101]. This evidence concerns the gene TNF and Hyperglycemia.